BlackBerry Ltd (NASDAQ:BBRY) would consider exiting its handset business if it remains unprofitable, its chief executive officer has said, as the technology company looks to expand its corporate reach with investments, acquisitions and partnerships. BlackBerry Ltd (NASDAQ:BBRY) shares after opening at $8.00 moved to $8.02 on last trade day and at the end of the day closed at $7.67. Company price to sales ratio in past twelve months was calculated as 0.32 and price to cash ratio as 1.47. BlackBerry Ltd (NASDAQ:BBRY) showed a negative weekly performance of -6.69%.
Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) the world’s biggest solar-panel maker, expects first-quarter shipments to have slumped by at least 30 percent from the previous three months. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) shares fell -4.16 % in last trading session and ended the day on $4.15. YGE return on equity ratio is recorded as -139.90% and its return on assets is -8.60%. Yingli Green Energy Hold. Co. Ltd. (ADR) (NYSE:YGE) yearly performance is 91.24%.
Boston Scientific Corporation (NYSE:BSX) introduced its lead-free subcutaneous implantable cardioverter defibrillator (S-ICD) in the Asia Pacific market. Recently, the first implant of the S-ICD was performed in Hong Kong. Boston Scientific Corporation (NYSE:BSX) shares moved down -4.51% in last trading session and was closed at $12.93 while trading in range of $12.88 – $13.59 – Boston Scientific Corporation (NYSE:BSX) year to date (YTD) performance is 7.57%.
Bio-Rad Laboratories Inc. (NYSE:BIO) announced that it has purchased GnuBIO. GnuBIO is developing a faster and fully integrated droplet-based DNA sequencing technology that incorporates all the functions of DNA sequencing into a single, integrated workflow for medical diagnostics as well as research markets. Bio-Rad Laboratories, Inc. (NYSE:BIO) weekly performance is -5.40%. On last trading day company shares ended up $122.70. Bio-Rad Laboratories, Inc. (NYSE:BIO) distance from 50-day simple moving average (SMA50) is -4.49%. Analysts mean target price for the company is $140.50.